Skip to content

Clinical trials

Active, not recruiting Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Active, not recruiting Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20091
20101
20131
20152
20161
20172
20181
20196
20206
20216
20226
20236
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center5
Incyte Corporation4
M.D. Anderson Cancer Center3
PharmaEssentia3
AbbVie2
Fred Hutchinson Cancer Center2
National Cancer Institute (NCI)2
Barbara Ann Karmanos Cancer Institute1
Celgene1
Center for International Blood and Marrow Transplant Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders42
Myelodysplastic Syndromes22
Primary Myelofibrosis20
Leukemia, Myeloid, Acute15
Leukemia, Myelomonocytic, Chronic14
Precursor Cell Lymphoblastic Leukemia-Lymphoma10
Thrombocythemia, Essential10
Lymphoma, Non-Hodgkin8
Hodgkin Disease7
Leukemia, Lymphocytic, Chronic, B-Cell7

Trials

Showing 51 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.